Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 949 to 954 of 954 entries
Sorted by: Best Match Show Resources per page
Peripunctal Mass Lesions: Clinicopathological Analysis and Surgical Outcomes-A Multicentric Series.

Ophthalmic plastic and reconstructive surgery

Nair AG, Mukherjee B, Kamal S, Singh S, Alam MS, Nisar SP, Koka K, Gopinathan I.
PMID: 34284425
Ophthalmic Plast Reconstr Surg. 2021 Jul 19; doi: 10.1097/IOP.0000000000002012. Epub 2021 Jul 19.

PURPOSE: To report the epidemiology, histopathological spectrum, and surgical outcomes of peripunctal mass lesions.METHODS: Multicentric retrospective case series involving 6 centers in India. All cases of peripunctal masses with histopathological diagnoses and minimum follow up of 3 months were...

Cite
Nair AG, Mukherjee B, Kamal S, et al. Peripunctal Mass Lesions: Clinicopathological Analysis and Surgical Outcomes-A Multicentric Series. Ophthalmic Plast Reconstr Surg. 2021;doi: 10.1097/IOP.0000000000002012.
Nair, A. G., Mukherjee, B., Kamal, S., Singh, S., Alam, M. S., Nisar, S. P., Koka, K., & Gopinathan, I. (2021). Peripunctal Mass Lesions: Clinicopathological Analysis and Surgical Outcomes-A Multicentric Series. Ophthalmic plastic and reconstructive surgery, . https://doi.org/10.1097/IOP.0000000000002012
Nair, Akshay Gopinathan, et al. "Peripunctal Mass Lesions: Clinicopathological Analysis and Surgical Outcomes-A Multicentric Series." Ophthalmic plastic and reconstructive surgery vol. (2021). doi: https://doi.org/10.1097/IOP.0000000000002012
Nair AG, Mukherjee B, Kamal S, Singh S, Alam MS, Nisar SP, Koka K, Gopinathan I. Peripunctal Mass Lesions: Clinicopathological Analysis and Surgical Outcomes-A Multicentric Series. Ophthalmic Plast Reconstr Surg. 2021 Jul 19; doi: 10.1097/IOP.0000000000002012. Epub 2021 Jul 19. PMID: 34284425.
Copy Download .nbib Format: NLM
Two-step screening method to identify α-synuclein aggregation inhibitors for Parkinson's disease.

Scientific reports

Hideshima M, Kimura Y, Aguirre C, Kakuda K, Takeuchi T, Choong CJ, Doi J, Nabekura K, Yamaguchi K, Nakajima K, Baba K, Nagano S, Goto Y, Nagai Y, Mochizuki H, Ikenaka K.
PMID: 35013421
Sci Rep. 2022 Jan 10;12(1):351. doi: 10.1038/s41598-021-04131-9.

Parkinson's disease is a neurodegenerative disease characterized by the formation of neuronal inclusions of α-synuclein in patient brains. As the disease progresses, toxic α-synuclein aggregates transmit throughout the nervous system. No effective disease-modifying therapy has been established, and preventing...

Cite
Hideshima M, Kimura Y, Aguirre C, et al. Two-step screening method to identify α-synuclein aggregation inhibitors for Parkinson's disease. Sci Rep. 2022;12(1):351doi: 10.1038/s41598-021-04131-9.
Hideshima, M., Kimura, Y., Aguirre, C., Kakuda, K., Takeuchi, T., Choong, C. J., Doi, J., Nabekura, K., Yamaguchi, K., Nakajima, K., Baba, K., Nagano, S., Goto, Y., Nagai, Y., Mochizuki, H., & Ikenaka, K. (2022). Two-step screening method to identify α-synuclein aggregation inhibitors for Parkinson's disease. Scientific reports, 12(1), 351. https://doi.org/10.1038/s41598-021-04131-9
Hideshima, Makoto, et al. "Two-step screening method to identify α-synuclein aggregation inhibitors for Parkinson's disease." Scientific reports vol. 12,1 (2022): 351. doi: https://doi.org/10.1038/s41598-021-04131-9
Hideshima M, Kimura Y, Aguirre C, Kakuda K, Takeuchi T, Choong CJ, Doi J, Nabekura K, Yamaguchi K, Nakajima K, Baba K, Nagano S, Goto Y, Nagai Y, Mochizuki H, Ikenaka K. Two-step screening method to identify α-synuclein aggregation inhibitors for Parkinson's disease. Sci Rep. 2022 Jan 10;12(1):351. doi: 10.1038/s41598-021-04131-9. PMID: 35013421.
Copy Download .nbib Format: NLM
Validation of the mitochondrial delivery of vitamin B.

Journal of pharmaceutical sciences

Yamada Y, Ishimaru T, Ikeda K, Harashima H.
PMID: 34478755
J Pharm Sci. 2021 Aug 31; doi: 10.1016/j.xphs.2021.08.033. Epub 2021 Aug 31.

Large amounts of ATP are produced in mitochondria especially in the brain and heart, where energy consumption is high compared with other organs. Thus, a decrease in ATP production in such organs could be a cause of many diseases...

Cite
Yamada Y, Ishimaru T, Ikeda K, et al. Validation of the mitochondrial delivery of vitamin B. J Pharm Sci. 2021;doi: 10.1016/j.xphs.2021.08.033.
Yamada, Y., Ishimaru, T., Ikeda, K., & Harashima, H. (2021). Validation of the mitochondrial delivery of vitamin B. Journal of pharmaceutical sciences, . https://doi.org/10.1016/j.xphs.2021.08.033
Yamada, Yuma, et al. "Validation of the mitochondrial delivery of vitamin B." Journal of pharmaceutical sciences vol. (2021). doi: https://doi.org/10.1016/j.xphs.2021.08.033
Yamada Y, Ishimaru T, Ikeda K, Harashima H. Validation of the mitochondrial delivery of vitamin B. J Pharm Sci. 2021 Aug 31; doi: 10.1016/j.xphs.2021.08.033. Epub 2021 Aug 31. PMID: 34478755.
Copy Download .nbib Format: NLM
Effect of exceeding compliance voltage on speech perception in cochlear implants.

Hearing research

Saoji AA, Adkins WJ, Olund AP, Nelson-Bakkum ER, Koka K.
PMID: 33253993
Hear Res. 2021 Feb;400:108112. doi: 10.1016/j.heares.2020.108112. Epub 2020 Nov 13.

OBJECTIVES: In cochlear implants, the maximum current I (Amperes) that can be delivered on a cochlear implant electrode is determined by V = I * R, where V = compliance voltage (Volts) and R = electrode impedance (Ohms). Generally,...

Cite
Saoji AA, Adkins WJ, Olund AP, et al. Effect of exceeding compliance voltage on speech perception in cochlear implants. Hear Res. 2020;400:108112doi: 10.1016/j.heares.2020.108112.
Saoji, A. A., Adkins, W. J., Olund, A. P., Nelson-Bakkum, E. R., & Koka, K. (2021). Effect of exceeding compliance voltage on speech perception in cochlear implants. Hearing research, 400108112. https://doi.org/10.1016/j.heares.2020.108112
Saoji, Aniket A, et al. "Effect of exceeding compliance voltage on speech perception in cochlear implants." Hearing research vol. 400 (2021): 108112. doi: https://doi.org/10.1016/j.heares.2020.108112
Saoji AA, Adkins WJ, Olund AP, Nelson-Bakkum ER, Koka K. Effect of exceeding compliance voltage on speech perception in cochlear implants. Hear Res. 2021 Feb;400:108112. doi: 10.1016/j.heares.2020.108112. Epub 2020 Nov 13. PMID: 33253993.
Copy Download .nbib Format: NLM
Gut microbiota, determined by dietary nutrients, drive modification of the plasma lipid profile and insulin resistance.

iScience

Watanabe Y, Fujisaka S, Ikeda K, Ishikawa M, Yamada T, Nawaz A, Kado T, Kuwano T, Nishimura A, Bilal M, Liu J, Yagi K, Hase K, Tobe K.
PMID: 33997711
iScience. 2021 Apr 16;24(5):102445. doi: 10.1016/j.isci.2021.102445. eCollection 2021 May 21.

The gut microbiota metabolizes the nutrients to produce various metabolites that play crucial roles in host metabolism. However, the links between the microbiota established by different nutrients and the microbiota-influenced changes in the plasma lipids remain unclear. Diets rich...

Cite
Watanabe Y, Fujisaka S, Ikeda K, et al. Gut microbiota, determined by dietary nutrients, drive modification of the plasma lipid profile and insulin resistance. iScience. 2021;24(5):102445doi: 10.1016/j.isci.2021.102445.
Watanabe, Y., Fujisaka, S., Ikeda, K., Ishikawa, M., Yamada, T., Nawaz, A., Kado, T., Kuwano, T., Nishimura, A., Bilal, M., Liu, J., Yagi, K., Hase, K., & Tobe, K. (2021). Gut microbiota, determined by dietary nutrients, drive modification of the plasma lipid profile and insulin resistance. iScience, 24(5), 102445. https://doi.org/10.1016/j.isci.2021.102445
Watanabe, Yoshiyuki, et al. "Gut microbiota, determined by dietary nutrients, drive modification of the plasma lipid profile and insulin resistance." iScience vol. 24,5 (2021): 102445. doi: https://doi.org/10.1016/j.isci.2021.102445
Watanabe Y, Fujisaka S, Ikeda K, Ishikawa M, Yamada T, Nawaz A, Kado T, Kuwano T, Nishimura A, Bilal M, Liu J, Yagi K, Hase K, Tobe K. Gut microbiota, determined by dietary nutrients, drive modification of the plasma lipid profile and insulin resistance. iScience. 2021 Apr 16;24(5):102445. doi: 10.1016/j.isci.2021.102445. eCollection 2021 May 21. PMID: 33997711; PMCID: PMC8105675.
Copy Download .nbib Format: NLM
The prevalence and impact of sarcopenia in females undergoing total hip arthroplasty: A prospective study.

Modern rheumatology

Ueoka K, Kabata T, Kajino Y, Inoue D, Ohmori T, Ueno T, Yoshitani J, Yamamuro Y, Taninaka A, Kato S, Yahata T, Tsuchiya H.
PMID: 33719865
Mod Rheumatol. 2021 Mar 30;1-6. doi: 10.1080/14397595.2021.1899603. Epub 2021 Mar 30.

OBJECTIVES: Although both sarcopenia and hip disease decrease physical function, few studies have investigated the association. We investigated the prevalence of sarcopenia in patients awaiting total hip arthroplasty for osteoarthritis and examined the impact of sarcopenia on pre- and...

Cite
Ueoka K, Kabata T, Kajino Y, et al. The prevalence and impact of sarcopenia in females undergoing total hip arthroplasty: A prospective study. Mod Rheumatol. 2021;1-6doi: 10.1080/14397595.2021.1899603.
Ueoka, K., Kabata, T., Kajino, Y., Inoue, D., Ohmori, T., Ueno, T., Yoshitani, J., Yamamuro, Y., Taninaka, A., Kato, S., Yahata, T., & Tsuchiya, H. (2021). The prevalence and impact of sarcopenia in females undergoing total hip arthroplasty: A prospective study. Modern rheumatology, 1-6. https://doi.org/10.1080/14397595.2021.1899603
Ueoka, Ken, et al. "The prevalence and impact of sarcopenia in females undergoing total hip arthroplasty: A prospective study." Modern rheumatology vol. (2021): 1-6. doi: https://doi.org/10.1080/14397595.2021.1899603
Ueoka K, Kabata T, Kajino Y, Inoue D, Ohmori T, Ueno T, Yoshitani J, Yamamuro Y, Taninaka A, Kato S, Yahata T, Tsuchiya H. The prevalence and impact of sarcopenia in females undergoing total hip arthroplasty: A prospective study. Mod Rheumatol. 2021 Mar 30;1-6. doi: 10.1080/14397595.2021.1899603. Epub 2021 Mar 30. PMID: 33719865.
Copy Download .nbib Format: NLM
Showing 949 to 954 of 954 entries